RPRX — Royalty Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual balance sheet for Royalty Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,649	2,803	2,428	1,234	1,771
Net Total Accounts Receivable
Net Total Receivables	39.2	68.3	36.6	36.6	27
Total Other Current Assets
Total Current Assets	2,697	2,878	2,555	1,274	1,802
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	16,020	17,516	16,813	16,382	18,223
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	308	171	1,167	161	1,254
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	11,202	11,739	11,185	9,855	11,276
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	4,819	5,777	5,628	6,526	6,947
Total Liabilities & Shareholders' Equity	16,020	17,516	16,813	16,382	18,223
Total Common Shares Outstanding